RESUMO
Despite the enormous morbidity attributed to schistosomiasis, there is still no vaccine to combat the disease for the hundreds of millions of infected people. The anthelmintic drug, praziquantel, is the mainstay treatment option, although its molecular mechanism of action remains poorly defined. Praziquantel treatment damages the outermost surface of the parasite, the tegument, liberating surface antigens from dying worms that invoke a robust immune response which in some subjects results in immunologic resistance to reinfection. Herein we term this phenomenon Drug-Induced Vaccination (DIV). To identify the antigenic targets of DIV antibodies in urogenital schistosomiasis, we constructed a recombinant proteome array consisting of approximately 1,000 proteins informed by various secretome datasets including validated proteomes and bioinformatic predictions. Arrays were screened with sera from human subjects treated with praziquantel and shown 18 months later to be either reinfected (chronically infected subjects, CI) or resistant to reinfection (DIV). IgG responses to numerous antigens were significantly elevated in DIV compared to CI subjects, and indeed IgG responses to some antigens were completely undetectable in CI subjects but robustly recognized by DIV subjects. One antigen in particular, a cystatin cysteine protease inhibitor stood out as a unique target of DIV IgG, so recombinant cystatin was produced, and its vaccine efficacy assessed in a heterologous Schistosoma mansoni mouse challenge model. While there was no significant impact of vaccination with adjuvanted cystatin on adult worm numbers, highly significant reductions in liver egg burdens (45-55%, P<0.0001) and intestinal egg burdens (50-54%, P<0.0003) were achieved in mice vaccinated with cystatin in two independent trials. This study has revealed numerous antigens that are targets of DIV antibodies in urogenital schistosomiasis and offer promise as subunit vaccine targets for a drug-linked vaccination approach to controlling schistosomiasis.
Assuntos
Antígenos de Helmintos/imunologia , Mapeamento de Epitopos , Interações Hospedeiro-Patógeno/efeitos dos fármacos , Interações Hospedeiro-Patógeno/imunologia , Praziquantel/farmacologia , Schistosoma haematobium/imunologia , Esquistossomose Urinária/imunologia , Animais , Anticorpos Anti-Helmínticos/imunologia , Biologia Computacional/métodos , Modelos Animais de Doenças , Mapeamento de Epitopos/métodos , Proteínas de Helminto/imunologia , Humanos , Imunização , Imunoglobulina G/imunologia , Camundongos , Carga Parasitária , Proteômica/métodos , Vacinas Protozoárias/administração & dosagem , Vacinas Protozoárias/imunologia , Esquistossomose Urinária/parasitologia , Esquistossomose Urinária/prevenção & controle , VacinaçãoRESUMO
HIV-1 infection disproportionately affects women in sub-Saharan Africa, where areas of high HIV-1 prevalence and Schistosoma haematobium endemicity largely overlap. Female genital schistosomiasis (FGS), an inflammatory disease caused by S. haematobium egg deposition in the genital tract, has been associated with prevalent HIV-1 infection. Elevated levels of the chemokines MIP-1α (CCL-3), MIP-1ß (CCL-4), IP-10 (CXCL-10), and IL-8 (CXCL-8) in cervicovaginal lavage (CVL) have been associated with HIV-1 acquisition. We hypothesize that levels of cervicovaginal cytokines may be raised in FGS and could provide a causal mechanism for the association between FGS and HIV-1. In the cross-sectional BILHIV study, specimens were collected from 603 female participants who were aged 18-31 years, sexually active, not pregnant and participated in the HPTN 071 (PopART) HIV-1 prevention trial in Zambia. Participants self-collected urine, and vaginal and cervical swabs, while CVLs were clinically obtained. Microscopy and Schistosoma circulating anodic antigen (CAA) were performed on urine. Genital samples were examined for parasite-specific DNA by PCR. Women with FGS (n=28), defined as a positive Schistosoma PCR from any genital sample were frequency age-matched with 159 FGS negative (defined as negative Schistosoma PCR, urine CAA, urine microscopy, and colposcopy imaging) women. Participants with probable FGS (n=25) (defined as the presence of either urine CAA or microscopy in combination with one of four clinical findings suggestive of FGS on colposcope-obtained photographs) were also included, for a total sample size of 212. The concentrations of 17 soluble cytokines and chemokines were quantified by a multiplex bead-based immunoassay. There was no difference in the concentrations of cytokines or chemokines between participants with and without FGS. An exploratory analysis of those women with a higher FGS burden, defined by ≥2 genital specimens with detectable Schistosoma DNA (n=15) showed, after adjusting for potential confounders, a higher Th2 (IL-4, IL-5, and IL-13) and pro-inflammatory (IL-15) expression pattern in comparison to FGS negative women, with differences unlikely to be due to chance (p=0.037 for IL-4 and p<0.001 for IL-5 after adjusting for multiple testing). FGS may alter the female genital tract immune environment, but larger studies in areas of varying endemicity are needed to evaluate the association with HIV-1 vulnerability.
Assuntos
Colo do Útero/fisiologia , Infecções por HIV/imunologia , HIV-1/fisiologia , Schistosoma haematobium/fisiologia , Esquistossomose Urinária/imunologia , Vagina/fisiologia , Animais , Antígenos de Helmintos/urina , Estudos Transversais , Citocinas/metabolismo , Doenças Endêmicas , Feminino , Glicoproteínas/urina , Infecções por HIV/epidemiologia , Proteínas de Helminto/urina , Humanos , Prevalência , Esquistossomose Urinária/epidemiologia , Vagina/patologia , Zâmbia/epidemiologiaRESUMO
AIMS: Schistosomiasis and malaria are endemic in sub-Saharan Africa where Schistosoma haematobium (Sh) and Plasmodium falciparum (Pf) coinfections are thus frequent. We explored the effect of Sh infection on antibody responses directed to Pf merozoite antigens and on malaria susceptibility in Beninese children. METHODS AND RESULTS: A total of 268 children were followed during a malaria transmission season. Detection of Pf infection was performed by microscopy and rapid diagnostic tests. Sh infection was determined in urine by microscopy. Antimalarial antibody, cytokine and HLA-G concentrations were quantified by ELISA. The expression of HLA-G receptors by immune cells was assessed by flow cytometry. Children infected by Sh had higher concentrations of IgG1 directed to MSP3 and GLURPR0 , IgG2 directed to GLURPR0 and IgG3 directed to MSP3, GLURPR0 and GLURPR2 and have lower Pf densities than those uninfected by Sh. No difference in cytokine and HLA-G concentrations was observed between Sh egg carriers and non-carriers. CONCLUSION: Schistosoma haematobium modulates host immune responses directed to Pf antigens. The absence of immune downregulation usually observed during helminth infections is surprising in our study. We hypothesize that the stage of Sh development could partly explain the immune pathways leading to increased antibody levels that favour better control of Pf parasitemia.
Assuntos
Anticorpos Antiprotozoários/sangue , Antimaláricos/imunologia , Malária Falciparum/imunologia , Plasmodium falciparum/imunologia , Schistosoma haematobium/imunologia , Esquistossomose Urinária/imunologia , Animais , Antígenos de Protozoários/imunologia , Antimaláricos/uso terapêutico , Benin , Criança , Pré-Escolar , Coinfecção/parasitologia , Citocinas/sangue , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Malária Falciparum/complicações , Masculino , Esquistossomose Urinária/complicações , Esquistossomose Urinária/tratamento farmacológicoRESUMO
BACKGROUND: Allergies and autoimmune disorders are less prevalent in areas where parasitic infections are abundant. The relationship between schistosomiasis, Chitinase 3-Like 1 protein (YKL-40), an inflammatory marker, and antinuclear antibodies (ANA), an allergy marker, was investigated in pre-school-aged children (1-5 years old) living in an area endemic to Schistosoma haematobium infection. METHODS: Cross-sectional study including 145 participants, 66 females and 79 males. S. haematobium infection was diagnosed using the urine filtration technique. Levels of YKL-40 and antinuclear antibodies concentrations were determined using enzyme-linked immunosorbent assay. RESULTS: The prevalence of S. haematobium infection was 21.4 % (n = 31) with 114 not infected, 18 with light and 13 with moderate infections. YKL-40 levels were higher in the S. haematobium-infected group than in the uninfected group (P = 0.038). However, S. haematobium infection intensity did not correlate with YKL-40 levels. ANA levels were significantly higher in uninfected children than in infected children (P = 0.028). There was a significant inverse relationship between ANA levels and schistosome infection intensity (r = -0.225, P = 0.016). The correlation between ANA levels and YKL-40 levels was not significant. CONCLUSION: Inflammatory marker in pre-school-aged children living in an area endemic for schistosomiasis indicate YKL-40 as a possible biomarker of S. haematobium infection in pre-school-aged children, warranting further investigations in a longitudinal study. The study gives an insight into allergy as ANA levels were higher in schistosome-uninfected than infected participants, further studies on allergies are needed.
CONTEXTE: Les allergies et les troubles auto-immunes sont moins répandus dans les régions où les infections parasitaires sont abondantes. La relation entre la schistosomiase, la protéine Chitinase 3-Like 1 (YKL-40), un marqueur antiinflammatoire, et les anticorps antinucléaires (AAN), un marqueur d'allergie, a été étudiée chez des enfants d'âge préscolaire (1 à 5 ans) vivant dans une zone endémique pour l'infection à Schistosoma haematobium. MÉTHODES: Etude transversale portant sur 145 participants, 66 de sexe féminin et 79 de sexe masculin. L'infection à S. haematobium a été diagnostiquée à l'aide de la technique de filtration de l'urine. Les niveaux de YKL-40 et les concentrations d'AAN ont été déterminés en utilisant un dosage immunoenzymatique . RÉSULTATS: La prévalence de l'infection à S. haematobium était de 21,4% (n = 31) avec 114 non infectés, 18 avec des infections légères et 13 avec des infections modérées. Les niveaux de YKL-40 étaient plus élevés dans le groupe infecté par S. haematobium que dans le groupe non infecté (p = 0,038). Cependant, l'intensité de l'infection à S. haematobium ne corrélait pas avec les niveaux de YKL-40. Les niveaux d'AAN étaient significativement plus élevés chez les enfants non infectés que chez les infectés (p = 0,028). Il y avait une relation inverse significative entre les niveaux d'AAN et l'intensité de l'infection schistosomique (r = -0,225, p = 0,016). La corrélation entre les niveaux d'AAN et les niveaux de YKL-40 n'était pas significative. CONCLUSION: Les marqueurs d'inflammation et les marqueurs d'allergie chez les enfants d'âge préscolaire vivant dans une zone endémique pour la schistosomiase indiquent YKL-40 comme biomarqueur possible de l'infection par S. haematobium chez les enfants d'âge préscolaire, ce qui justifie des investigations supplémentaires dans une étude longitudinale. Comme les niveaux d'AAN étaient plus élevés chez les participants non infectés que chez ceux infectés par le schistosome, d'autres études sur les allergies sont nécessaires.
Assuntos
Esquistossomose Urinária/epidemiologia , Anticorpos Antinucleares/sangue , Biomarcadores/sangue , Serviços de Saúde da Criança , Pré-Escolar , Proteína 1 Semelhante à Quitinase-3/sangue , Estudos Transversais , Doenças Endêmicas , Feminino , Humanos , Lactente , Inflamação/sangue , Estudos Longitudinais , Masculino , População Rural , Esquistossomose Urinária/sangue , Esquistossomose Urinária/imunologia , Zimbábue/epidemiologiaRESUMO
Interleukin-4 (IL-4) is crucial in many helminth infections, but its role in urogenital schistosomiasis, infection with Schistosoma haematobium worms, remains poorly understood due to a historical lack of animal models. The bladder pathology of urogenital schistosomiasis is caused by immune responses to eggs deposited in the bladder wall. A range of pathology occurs, including urothelial hyperplasia and cancer, but associated mechanisms and links to IL-4 are largely unknown. We modeled urogenital schistosomiasis by injecting the bladder walls of IL-4 receptor-alpha knockout (Il4ra-/- ) and wild-type mice with S. haematobium eggs. Readouts included bladder histology and ex vivo assessments of urothelial proliferation, cell cycle, and ploidy status. We also quantified the effects of exogenous IL-4 on urothelial cell proliferation in vitro, including cell cycle status and phosphorylation patterns of major downstream regulators in the IL-4 signaling pathway. There was a significant decrease in the intensity of granulomatous responses to bladder-wall-injected S. haematobium eggs in Il4ra-/- versus wild-type mice. S. haematobium egg injection triggered significant urothelial proliferation, including evidence of urothelial hyper-diploidy and cell cycle skewing in wild-type but not Il4ra-/- mice. Urothelial exposure to IL-4 in vitro led to cell cycle polarization and increased phosphorylation of AKT. Our results show that IL-4 signaling is required for key pathogenic features of urogenital schistosomiasis and that particular aspects of this signaling pathway may exert these effects directly on the urothelium. These findings point to potential mechanisms by which urogenital schistosomiasis promotes bladder carcinogenesis.
Assuntos
Interleucina-4/imunologia , Schistosoma haematobium/imunologia , Esquistossomose Urinária , Transdução de Sinais/fisiologia , Bexiga Urinária/patologia , Animais , Modelos Animais de Doenças , Camundongos , Esquistossomose Urinária/imunologia , Esquistossomose Urinária/patologiaRESUMO
BACKGROUND: Although Schistosoma haematobium infection has been reported to be associated with alterations in immune function, in particular immune hyporesponsiveness, there have been only few studies that have used the approach of removing infection by drug treatment to establish this and to understand the underlying molecular mechanisms. METHODS: Schistosoma haematobium-infected schoolchildren were studied before and after praziquantel treatment and compared with uninfected controls. Cellular responses were characterized by cytokine production and flow cytometry, and in a subset of children RNA sequencing (RNA-Seq) transcriptome profiling was performed. RESULTS: Removal of S haematobium infection resulted in increased schistosome-specific cytokine responses that were negatively associated with CD4+CD25+FOXP3+ T-cells and accompanied by increased frequency of effector memory T-cells. Innate responses to Toll like receptor (TLR) ligation decreased with treatment and showed positive association with CD4+CD25+FOXP3+ T-cells. At the transcriptome level, schistosome infection was associated with enrichment in cell adhesion, whereas parasite removal was associated with a more quiescent profile. Further analysis indicated that alteration in cellular energy metabolism was associated with S haematobium infection and that the early growth response genes 2 and 3 (EGR 2 and EGR3), transcription factors that negatively regulate T-cell activation, may play a role in adaptive immune hyporesponsiveness. CONCLUSIONS: Using a longitudinal study design, we found contrasting effects of schistosome infection on innate and adaptive immune responses. Whereas the innate immune system appears more activated, the adaptive immunity is in a hyporesponsive state reflected in alterations in CD4+CD25+FOXP3+ T-cells, cellular metabolism, and transcription factors involved in anergy.
Assuntos
Anti-Helmínticos/uso terapêutico , Citocinas/imunologia , Praziquantel/uso terapêutico , Esquistossomose Urinária/imunologia , Transcriptoma , Imunidade Adaptativa , Animais , Criança , Feminino , Citometria de Fluxo , Gabão/epidemiologia , Humanos , Imunidade Inata , Estudos Longitudinais , Masculino , RNA-Seq , Esquistossomose Urinária/tratamento farmacológicoRESUMO
Dipstick Dye Immunoassay (DDIA) and Indirect Haemagglutination Assay (IHA), are two commercially available kits which have been widely used for screening Schistosoma japonicum in P.R. China. Whether they can be used for screening of Schistosoma haematobium are not clear. In order to evaluate the diagnostic efficiency of DDIA and IHA for screening Schistosoma haematobium, serum samples were collected from pupils in endemic areas in Zambia, Southern Africa, and tested by DDIA and IHA by single-blind manner. Meanwhile, the pupils were microscopically examined by infection with Schistosoma and soil-transmitted helminths, visually observed for parasite eggs. Of the enrolled 148 pupils, 61% tested positive for S. haematobium infection, while 31% and 36% of pupils were infected with hookworm and Ascaris respectively. Regarding the parasitological tests as reference standard, for the diagnosis of S. haematobium infection, IHA performed higher sensitivity (74%, 95% CI: 65%-83%) than that of DDIA (60%, 95%CI: 49%-70%). The sensitivities of IHA and DDIA are significant higher in 10-14 years old students than those of 7-9 years old group. The specificity of DDIA and IHA were 61% (95%CI: 49%-74%) and 72% (95%CI: 60%-84%), respectively. The co-infection with STHs decreased the specificity of DDIA but had no impact on that of IHA. Our study indicated that IHA has more potential as an alternative diagnostic tool for identifying schistosomiasis haematobium but need further improvement.
Assuntos
Anticorpos Anti-Helmínticos/sangue , Schistosoma haematobium/imunologia , Schistosoma japonicum/imunologia , Esquistossomose Urinária/diagnóstico , Esquistossomose Japônica/diagnóstico , Adolescente , Animais , Criança , Coinfecção , Feminino , Testes de Hemaglutinação , Humanos , Imunoensaio , Masculino , Programas de Rastreamento , Esquistossomose Urinária/sangue , Esquistossomose Urinária/imunologia , Esquistossomose Japônica/epidemiologia , Sensibilidade e Especificidade , Método Simples-Cego , ZâmbiaRESUMO
BACKGROUND: Schistosomiasis is a devastating parasitic disease. The mainstay of schistosomiasis control is by praziquantel treatment. The study aimed to determine benefits of annual chemotherapy of schistosomiasis on development of protective immunity in school children in a selected endemic rural area in Zimbabwe. METHODS: Urine specimens from 212 school children (7-13 years) were collected and examined to determine prevalence, intensity and reinfection of S.haematobium at baseline, 6 weeks and 2 years following annual rounds of praziquantel treatment. Blood samples from the participants were assayed for total and S. haematobium (Sh13)-specific antibodies before and 2 years after annual rounds of treatment. RESULTS: Annual treatment reduced the prevalence of S. haematobium infection (p < 0.05) from 23.1% at baseline to 0.47% after 2 years. Overall cure rate was 97.8%. Intensity of infection declined (p < 0.05) from 15.9 eggs/10 ml urine at baseline to 2 eggs/10 ml urine. After two years, overall rate of reinfection was 0.96%. At baseline, total IgG4 was higher in S. haematobium-infected children (p = 0.042) ,while all other immunoglobulins were within normal ranges. There was an increase in total IgG2 (p = 0.044) levels and a decrease in total IgG4 (p = 0.031) levels 2 years post-treatment; and no significant changes in other total immunoglobulins. Schistosoma-infected children at baseline showed an increase in anti-Sh13 IgG1 (p = 0.005) and a decrease in Sh13 IgG4 levels (p = 0.012) following treatment. CONCLUSION: Annual praziquantel treatment delivered to school children over 2 years significantly reduce prevalence, intensity of infection and reinfection of S. haematobium infection. Treatment was also observed to cause a reduction in schistosome-specific blocking IgG4 and an increase in Schistosoma-specific protecting IgG1.
Assuntos
Imunidade Adaptativa , Anti-Helmínticos/uso terapêutico , Esquistossomose Urinária/tratamento farmacológico , Adolescente , Animais , Anticorpos Anti-Helmínticos/sangue , Criança , Feminino , Hematúria/patologia , Hematúria/urina , Humanos , Imunoglobulina G/metabolismo , Isotipos de Imunoglobulinas/sangue , Estudos Longitudinais , Masculino , Óvulo/citologia , Praziquantel/uso terapêutico , Prevalência , Schistosoma haematobium/crescimento & desenvolvimento , Schistosoma haematobium/imunologia , Esquistossomose Urinária/epidemiologia , Esquistossomose Urinária/imunologia , Resultado do Tratamento , Zimbábue/epidemiologiaRESUMO
BACKGROUND: Schistosomiasis increases the risk of human immunodeficiency virus (HIV) acquisition in women by mechanisms that are incompletely defined. Our objective was to determine how the cervical environment is impacted by Schistosoma haematobium or Schistosoma mansoni infection by quantifying gene expression in the cervical mucosa and cytokine levels in cervicovaginal lavage fluid. METHODS: We recruited women with and those without S. haematobium infection and women with and those without S. mansoni infection from separate villages in rural Tanzania with high prevalences of S. haematobium and S. mansoni, respectively. Infection status was determined by urine and stool microscopy and testing for serum circulating anodic antigen. RNA was extracted from cervical cytobrush samples for transcriptome analysis. Cytokine levels were measured by magnetic bead immunoassay. RESULTS: In the village where S. haematobium was prevalent, 110 genes were differentially expressed in the cervical mucosa of 18 women with versus 39 without S. haematobium infection. Among the 27 cytokines analyzed in cervicovaginal lavage fluid from women in this village, the level of interleukin 15 was lower in the S. haematobium-infected group (62.8 vs 102.9 pg/mL; adjusted P = .0013). Differences were not observed in the S. mansoni-prevalent villages between 11 women with and 29 without S. mansoni infection. CONCLUSIONS: We demonstrate altered cervical mucosal gene expression and lower interleukin 15 levels in women with S. haematobium infection as compared to those with S. mansoni infection, which may influence HIV acquisition and cancer risks. Studies to determine the effects of antischistosome treatment on these mucosal alterations are needed.
Assuntos
Interleucina-15/genética , Schistosoma haematobium/imunologia , Schistosoma mansoni/imunologia , Esquistossomose Urinária/imunologia , Esquistossomose mansoni/imunologia , Adulto , Animais , Feminino , Humanos , Mucosa/imunologia , Mucosa/parasitologia , Prevalência , População Rural , Esquistossomose Urinária/epidemiologia , Esquistossomose Urinária/parasitologia , Esquistossomose mansoni/epidemiologia , Esquistossomose mansoni/parasitologia , Tanzânia/epidemiologia , Adulto JovemRESUMO
AIMS: Previous studies have reported that chemotherapy of schistosomiasis by praziquantel in humans boosts protective antibody responses against S mansoni and S haematobium. A number of studies have reported schistosome-specific antibody levels before and after chemotherapy. Using these reports, a meta-analysis was conducted to identify predictors of population level change in schistosome-specific antibody levels after chemotherapy. METHODS AND RESULTS: Following a systematic review, 92 observations from 26 articles published between 1988 and 2013 were included in this study. Observations were grouped by antigen type and antibody isotypes for the classification and regression tree (CART) analysis. The study showed that the change in antibody levels was variable: (a) between different human populations and (b) according to the parasite antigen and antibody isotypes. Thus, while anti-worm responses predominantly increased after chemotherapy, anti-egg responses decreased or did not show a significant trend. The change in antibody levels depended on a combination of age and infection intensity for anti-egg IgA, IgM, IgG1, IgG2 and anti-worm IgM and IgG. CONCLUSION: The study results are consistent with praziquantel treatment boosting anti-worm antibody responses. However, there is considerable heterogeneity in post-treatment changes in specific antibody levels that is related to host age and pre-treatment infection intensity.
Assuntos
Anti-Helmínticos/uso terapêutico , Anticorpos Anti-Helmínticos/sangue , Praziquantel/uso terapêutico , Esquistossomose/tratamento farmacológico , Esquistossomose/imunologia , Animais , Anticorpos Anti-Helmínticos/imunologia , Humanos , Imunidade Humoral/efeitos dos fármacos , Schistosoma haematobium/efeitos dos fármacos , Schistosoma haematobium/imunologia , Schistosoma mansoni/efeitos dos fármacos , Schistosoma mansoni/imunologia , Esquistossomose Urinária/tratamento farmacológico , Esquistossomose Urinária/imunologia , Esquistossomose mansoni/imunologiaRESUMO
Schistosome worms infect over 200 million people worldwide. They live in the host's bloodstream and alter host immunity. Epidemiological data suggest that males and females have different responses to schistosome infection, but the effect of sex on systemic response is undetermined. Our objective was to characterize differences in peripheral blood transcriptional profiles in people with or without active Schistosoma haematobium infection and to determine whether this signature differs between males and females. mRNA was isolated using poly(A) selection and sequenced on an Illumina Hi-Seq4000 platform. Transcripts were aligned to the human hg19 reference genome and counted with the HTSeq package. Genes were compared for differential expression using DESeq2. Ingenuity Pathway Analysis (IPA) was used to identify gene networks altered in the presence of S. haematobium We enrolled 33 participants from villages in rural Tanzania where S. haematobium is endemic. After correction for multiple comparisons, we observed 383 differentially expressed genes between those with or without S. haematobium infection when sex was included as a covariate. Heat-mapping of the genes with >1.5-fold differences in gene expression revealed clustering by S. haematobium infection status. The top networks included development, cell death and survival, cell signaling, and immunologic disease pathways. We observed a distinct whole blood transcriptional profile, as well as differences in men and women, with S. haematobium infection. Additional studies are needed to determine the clinical effects of these divergent responses. Attention to sex-based differences should be included in studies of human schistosome infection.
Assuntos
Células Sanguíneas/imunologia , Células Sanguíneas/parasitologia , Perfilação da Expressão Gênica , Interações Hospedeiro-Patógeno , Schistosoma haematobium/imunologia , Esquistossomose Urinária/imunologia , Esquistossomose Urinária/patologia , Adolescente , Adulto , Animais , Feminino , Redes Reguladoras de Genes , Humanos , Masculino , Pessoa de Meia-Idade , Schistosoma haematobium/crescimento & desenvolvimento , Análise de Sequência de RNA , Fatores Sexuais , Tanzânia , Adulto JovemRESUMO
AIMS: Mouse bladder wall injection with Schistosoma haematobium eggs has been used to overcome limitations in animal models of urogenital schistosomiasis. However, the effect of the absence of cercarial infection on immune responses to eggs in this model is unknown. We hypothesized that cercarial infection would alter local bladder and systemic immune responses to eggs in this model. METHODS AND RESULTS: Mice were infected or not infected with S haematobium cercariae, and then, their bladder walls injected with S haematobium eggs or vehicle 5 weeks following cercarial infection. Three weeks later, mice were bled, sacrificed, perfused and their bladders harvested. Parasitological parameters and gross bladder pathology were not changed in egg-injected bladders by cercarial exposure. Figure S1 shows no changes in either granulomas or fibrosis. The only bladder cytokine upregulated in egg-injected bladders by cercarial exposure (vs no exposure) was leptin. Cercarial exposure, compared to no exposure, resulted in increased serum, IL-1α, IL-13 and TGF-ß in bladder egg-injected mice. CONCLUSION: Cercarial exposure altered systemic responses of several cytokines in bladder egg-injected mice, but surprisingly, only modified leptin expression in bladder tissue. This suggests that depending on the specific application, cercarial exposure may not be strictly necessary to model local immune responses in the bladder wall egg injection mouse model of urogenital schistosomiasis.
Assuntos
Schistosoma haematobium/imunologia , Esquistossomose Urinária/imunologia , Bexiga Urinária/imunologia , Animais , Cercárias/imunologia , Cricetinae , Citocinas/metabolismo , Modelos Animais de Doenças , Feminino , Granuloma/patologia , Camundongos Endogâmicos BALB C , Óvulo/imunologia , Esquistossomose Urinária/patologiaRESUMO
Background: Traditional microscopic examination of urine or stool for schistosome eggs lacks sensitivity compared to measurement of schistosome worm-derived circulating antigens in serum or urine. The ease and non-invasiveness of urine collection makes urine an ideal sample for schistosome antigen detection. In this study several user-friendly, lateral-flow (LF) based urine assays were evaluated against a composite reference that defined infection as detection of either eggs in urine or anodic antigen in serum. Method: In a Tanzanian population with a S. haematobium prevalence of 40-50% (S. mansoni prevalence <2%), clinical samples from 44 women aged 18 to 35 years were analyzed for Schistosoma infection. Urine and stool samples were examined microscopically for eggs, and serum samples were analyzed for the presence of the anodic antigen. Urines were further subjected to a set of LF assays detecting (circulating) anodic (CAA) and cathodic antigen (CCA) as well as antibodies against soluble egg antigens (SEA) and crude cercarial antigen preparation (SCAP). Results: The urine LF anodic antigen assay utilizing luminescent upconverting reporter particles (UCP) confirmed its increased sensitivity when performed with larger sample volume. Qualitatively, the anodic antigen assay performed on 250 µL urine matched the performance of the standard anodic antigen assay performed on 20 µL serum. However, the ratio of anodic antigen levels in urine vs. serum of individual patients varied with absolute levels always higher in serum. The 10 µL urine UCP-LF cathodic antigen assay correlated with the commercially available urine POC-CCA (40 µL) test, while conferring better sensitivity with a quantitative result. Urinary antibodies against SEA and SCAP overlap and correlate with the presence of urinary egg and serum anodic antigen levels. Conclusions: The UCP-LF anodic antigen assay using 250 µL of urine is an expedient user-friendly assay and a suitable non-invasive alternative to serum-based antigen testing and urinary egg detection. Individual biological differences in the clearance process of the circulating antigens are thought to explain the observed high variation in the type and level of antigen (anodic or cathodic) measured in urine or serum. Simultaneous detection of anodic and cathodic antigen may be considered to further increase accuracy.
Assuntos
Anticorpos Anti-Helmínticos , Antígenos de Helmintos , Schistosoma haematobium , Esquistossomose Urinária , Adolescente , Adulto , Animais , Anticorpos Anti-Helmínticos/imunologia , Anticorpos Anti-Helmínticos/urina , Antígenos de Helmintos/imunologia , Antígenos de Helmintos/urina , Feminino , Humanos , Schistosoma haematobium/imunologia , Schistosoma haematobium/metabolismo , Esquistossomose Urinária/diagnóstico , Esquistossomose Urinária/imunologia , Esquistossomose Urinária/urinaRESUMO
Schistosomiasis remains a major global health problem. Despite large-scale schistosomiasis control efforts, clear limitations such as possible emergence of drug resistance and reinfection rates highlight the need for an effective schistosomiasis vaccine. Schistosoma mansoni large subunit of calpain (Sm-p80)-based vaccine formulations have shown remarkable efficacy in protecting against S. mansoni challenge infections in mice and baboons. In this study, we evaluated the cross-species protective efficacy of Sm-p80 vaccine against S. japonicum and S. haematobium challenge infections in rodent models. We also elucidated the expression of Sm-p80 and Sm-p80 ortholog proteins in different developmental stages of S. mansoni, S. haematobium, and S. japonicum. Immunization with Sm-p80 vaccine reduced worm burden by 46.75% against S. japonicum challenge infection in mice. DNA prime/protein boost (1 + 1 dose administered on a single day) resulted in 26.95% reduction in worm burden in S. haematobium-hamster infection/challenge model. A balanced Th1 (IFN-γ, TNF-α, IL-2, and IL-12) and Th2 (IL-4, IgG1) type of responses were observed following vaccination in both S. japonicum and S. haematobium challenge trials and these are associated with the prophylactic efficacy of Sm-p80 vaccine. Immunohistochemistry demonstrated that Sm-p80/Sm-p80 ortholog proteins are expressed in different life cycle stages of the three major human species of schistosomes studied. The data presented in this study reinforce the potential of Sm-p80-based vaccine for both hepatic/intestinal and urogenital schistosomiasis occurring in different geographical areas of the world. Differential expression of Sm-p80/Sm-p80 protein orthologs in different life cycle makes this vaccine potentially useful in targeting different levels of infection, disease, and transmission.
Assuntos
Antígenos de Helmintos/imunologia , Vacinas Protozoárias/imunologia , Schistosoma haematobium/imunologia , Schistosoma japonicum/imunologia , Schistosoma mansoni/imunologia , Esquistossomose Urinária/prevenção & controle , Esquistossomose Japônica/prevenção & controle , Esquistossomose mansoni/prevenção & controle , Animais , Anticorpos Anti-Helmínticos/imunologia , Calpaína/imunologia , Cricetinae , Modelos Animais de Doenças , Feminino , Humanos , Imunoglobulina G/imunologia , Interleucina-12/biossíntese , Interleucina-2/biossíntese , Interleucina-4/biossíntese , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Papio , Schistosoma haematobium/crescimento & desenvolvimento , Schistosoma japonicum/crescimento & desenvolvimento , Schistosoma mansoni/crescimento & desenvolvimento , Esquistossomose Urinária/imunologia , Esquistossomose Urinária/parasitologia , Esquistossomose Japônica/imunologia , Esquistossomose Japônica/parasitologia , Esquistossomose mansoni/imunologia , Esquistossomose mansoni/parasitologia , Fator de Necrose Tumoral alfa/biossíntese , Vacinação , Vacinas de DNA/imunologiaRESUMO
BACKGROUND: After alleged stop of transmission of schistosomiasis and further down the line in post elimination settings, sensitive tools are required to monitor infection status to prevent potential re-emergence. In Rahala, where transmission cycle of Schistosoma haematobium is interrupted since 2004 but where 30% of snails are still infected by S. bovis, potential human S. bovis infection can't be excluded. As methods based on egg-counts do not provide the required sensitivity, antibody or antigen assays are envisaged as the most appropriate tools for this type of monitoring. METHODS: In this pilot study, the performances of three assays were compared: two commercially available antibody tests (ELISA and haemagglutination format) indicating exposure, and an antigen test (lateral flow strip format) demonstrating active infection. All 37 recruited study participants resided in Rahala (Akka, province Tata, Morocco). Participants had been diagnosed and cured from schistosomiasis in the period between 1983 and 2003. In 2015 these asymptomatic participants provided fresh clinical samples (blood and urine) for analysis with the aforementioned diagnostics tests. RESULTS: No eggs were identified in the urine of the 37 participants. The haemagglutination test indicated 6 antibody positives whereas the ELISA indicated 28 antibody positives, one indecisive and one false positive. ELISA and haemagglutination results matched for 18 individuals, amongst which 5 out of 6 haemagglutination positives. With the antigen test (performed on paired serum and urine samples), serum from two participants (cured 21 and 32 years ago) indicated the presence of low levels of the highly specific Schistosoma circulating anodic antigen (CAA), demonstrating low worm level infections (less than 5 pg/ml corresponding to probably single worm pair). One tested also CAA positive with urine. ELISA indicated the presence of human anti-Schistosoma antibodies in these two CAA positive cases, haemagglutination results were negative. CONCLUSIONS: To prevent reemergence of schistosomiasis in Morocco current monitoring programs require specific protocols that include testing of antibody positives for active infection by the UCP-LF CAA test, the appropriate diagnostic tool to identify Schistosoma low grade infections in travelers, immigrants and assumed cured cases. The test is genus specific will also identify infections related to S. bovis.
Assuntos
Schistosoma/isolamento & purificação , Esquistossomose Urinária/diagnóstico , Adolescente , Adulto , Idoso , Animais , Anticorpos Anti-Helmínticos/sangue , Anticorpos Anti-Helmínticos/urina , Antígenos de Helmintos/sangue , Antígenos de Helmintos/imunologia , Antígenos de Helmintos/urina , Criança , Erradicação de Doenças , Ensaio de Imunoadsorção Enzimática/métodos , Feminino , Testes de Hemaglutinação/métodos , Humanos , Testes Imunológicos/métodos , Masculino , Pessoa de Meia-Idade , Marrocos , Contagem de Ovos de Parasitas , Projetos Piloto , Schistosoma/imunologia , Esquistossomose Urinária/imunologia , Esquistossomose Urinária/parasitologia , Esquistossomose Urinária/prevenção & controle , Adulto JovemRESUMO
Infections with helminths and Plasmodium spp. overlap in their geographical distribution. It has been postulated that helminth infections may influence malarial transmission by altering Plasmodium falciparum gametocytogenesis. This cross-sectional study assessed the effect of helminth infections on P. falciparum gametocyte carriage and on humoral immune responses to sexual stage antigens in Gabon. Schistosoma haematobium and filarial infections as well as P. falciparum asexual forms and gametocyte carriage were determined. The antibody responses measured were to sexual (Pfs230, Pfs48/45) and asexual P. falciparum antigens (AMA1, MSP1, and GLURP). A total of 287 subjects were included. The prevalence of microscopically detectable P. falciparum asexual parasites was higher in S. haematobium-infected subjects in comparison to their uninfected counterparts (47% versus 26%, P = 0.003), but this was not different when filarial infections were considered. Plasmodium falciparum gametocyte carriage was similar between Schistosoma- or filaria-infected and uninfected subjects. We observed a significant decrease of Pfs48/45 immunoglobulin G titer in S. haematobium-infected subjects (P = 0.037), whereas no difference was seen for Pfs230 antibody titer, nor for antibodies to AMA1, MSP1, or GLURP. Our findings suggest an effect of S. haematobium on antibody responses to some P. falciparum gametocyte antigens that may have consequences for transmission-blocking immunity.
Assuntos
Anticorpos Antiprotozoários/biossíntese , Estágios do Ciclo de Vida/imunologia , Malária Falciparum/imunologia , Plasmodium falciparum/imunologia , Schistosoma haematobium/imunologia , Esquistossomose Urinária/imunologia , Adolescente , Animais , Antígenos de Protozoários/genética , Antígenos de Protozoários/imunologia , Criança , Coinfecção , Estudos Transversais , Feminino , Gabão/epidemiologia , Expressão Gênica , Humanos , Imunidade Humoral , Estágios do Ciclo de Vida/genética , Malária Falciparum/epidemiologia , Malária Falciparum/parasitologia , Masculino , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/imunologia , Proteínas de Membrana/genética , Proteínas de Membrana/imunologia , Proteína 1 de Superfície de Merozoito/genética , Proteína 1 de Superfície de Merozoito/imunologia , Plasmodium falciparum/genética , Plasmodium falciparum/crescimento & desenvolvimento , Proteínas de Protozoários/genética , Proteínas de Protozoários/imunologia , Schistosoma haematobium/genética , Schistosoma haematobium/crescimento & desenvolvimento , Esquistossomose Urinária/epidemiologia , Esquistossomose Urinária/parasitologiaRESUMO
Areas prone to schistosomiasis are also at risk of malaria transmission. The interaction between the causal agents of the two diseases could modulate immune responses tailored toward protecting or aggravating morbidity dynamics and impair Schistosoma diagnostic precision. This study aimed at assessing the effect of Plasmodium spp. in concomitant infection with Schistosoma haematobium in modulation of anti-Schistosoma IgG antibodies. The school-based cross-sectional study recruited a total of 322 children screened for S. haematobium and Plasmodium spp. Levels of IgG against S. haematobium-soluble egg antigen (SEA) in single S. haematobium/malaria parasites infection and co-infection of the two parasites in schoolchildren were determined. Data were analyzed using χ(2), Fisher's exact test, and Tukey's multiple comparison test analyses. The prevalence of single infection by S. haematobium, Plasmodium spp., and concurrent infection due to the two pathogens was 27.7, 41.0, and 9.3%, respectively (p < 0.0001). Anti-Schistosoma IgG production during co-infection of the two pathogens (1.950 ± 0.742 AU) was significantly higher than the value recorded for single malaria parasites' infection (1.402 ± 0.670 AU) (p < 0.01) but not in S. haematobium infection (1.591 ± 0.604 AU) (p > 0.05). The anti-Schistosoma IgG production in co-infection status was however dependent on the intensity of Plasmodium spp. with individuals having high intensity of malaria parasites recording lower anti-Schistosoma IgG. This study has implication for diagnosis of schistosomiasis where anti-Schistosoma IgG is used as an indicator of infection. Efforts should be made to control the two infections simultaneously in order not to undermine the efforts targeted toward the control of one.
Assuntos
Malária/epidemiologia , Plasmodium/imunologia , Schistosoma haematobium/imunologia , Esquistossomose Urinária/epidemiologia , Esquistossomose Urinária/imunologia , Adolescente , Animais , Anticorpos Antiprotozoários/biossíntese , Anticorpos Antiprotozoários/sangue , Especificidade de Anticorpos , Criança , Pré-Escolar , Coinfecção , Estudos Transversais , Feminino , Humanos , Imunoglobulina G/biossíntese , Imunoglobulina G/sangue , Malária/complicações , Malária/parasitologia , Masculino , Nigéria/epidemiologia , Plasmodium/isolamento & purificação , Prevalência , Schistosoma haematobium/isolamento & purificação , Esquistossomose Urinária/complicações , Adulto JovemRESUMO
BACKGROUND: Chronic schistosomiasis is associated with T cell hypo-responsiveness and immunoregulatory mechanisms, including induction of regulatory T cells (Tregs). However, little is known about Treg functional capacity during human Schistosoma haematobium infection. METHODOLOGY: CD4+CD25hiFOXP3+ cells were characterized by flow cytometry and their function assessed by analysing total and Treg-depleted PBMC responses to schistosomal adult worm antigen (AWA), soluable egg antigen (SEA) and Bacillus Calmette-Guérin (BCG) in S. haematobium-infected Gabonese children before and 6 weeks after anthelmintic treatment. Cytokines responses (IFN-γ, IL-5, IL-10, IL-13, IL-17 and TNF) were integrated using Principal Component Analysis (PCA). Proliferation was measured by CFSE. PRINCIPAL FINDINGS: S. haematobium infection was associated with increased Treg frequencies, which decreased post-treatment. Cytokine responses clustered into two principal components reflecting regulatory and Th2-polarized (PC1) and pro-inflammatory and Th1-polarized (PC2) cytokine responses; both components increased post-treatment. Treg depletion resulted in increased PC1 and PC2 at both time-points. Proliferation on the other hand, showed no significant difference from pre- to post-treatment. Treg depletion resulted mostly in increased proliferative responses at the pre-treatment time-point only. CONCLUSIONS: Schistosoma-associated CD4+CD25hiFOXP3+Tregs exert a suppressive effect on both proliferation and cytokine production. Although Treg frequency decreases after praziquantel treatment, their suppressive capacity remains unaltered when considering cytokine production whereas their influence on proliferation weakens with treatment.
Assuntos
Anti-Helmínticos/uso terapêutico , Citocinas/metabolismo , Regulação da Expressão Gênica/fisiologia , Praziquantel/uso terapêutico , Esquistossomose Urinária/tratamento farmacológico , Linfócitos T Reguladores/classificação , Adolescente , Antígenos CD4/imunologia , Criança , Estudos de Coortes , Feminino , Fatores de Transcrição Forkhead/imunologia , Humanos , Subunidade alfa de Receptor de Interleucina-2/imunologia , Estudos Longitudinais , Masculino , Fragmentos de Peptídeos/imunologia , Esquistossomose Urinária/imunologia , Esquistossomose Urinária/metabolismo , Linfócitos T Reguladores/imunologia , Linfócitos T Reguladores/metabolismoRESUMO
BACKGROUND: Elimination of schistosomiasis as a public health problem and interruption of transmission in selected areas are key goals of the World Health Organization for 2025. Conventional parasitological methods are insensitive for the detection of light-intensity infections. Techniques with high sensitivity and specificity are required for an accurate diagnosis in low-transmission settings and verification of elimination. We determined the accuracy of a urine-based up-converting phosphor-lateral flow circulating anodic antigen (UCP-LF CAA) assay for Schistosoma haematobium diagnosis in low-prevalence settings in Zanzibar, Tanzania. METHODOLOGY: A total of 1,740 urine samples were collected in 2013 from children on Pemba Island, from schools where the S. haematobium prevalence was <2%, 2-5%, and 5-10%, based on a single urine filtration. On the day of collection, all samples were tested for microhematuria with reagent strips and for the presence of S. haematobium eggs with microscopy. Eight months later, 1.5 ml of urine from each of 1,200 samples stored at -20°C were analyzed by UCP-LF CAA assay, while urine filtration slides were subjected to quality control (QCUF). In the absence of a true 'gold' standard, the diagnostic performance was calculated using latent class analyses (LCA). PRINCIPAL FINDINGS: The 'empirical' S. haematobium prevalence revealed by UCP-LF CAA, QCUF, and reagent strips was 14%, 5%, and 4%, respectively. LCA revealed a sensitivity of the UCP-LF CAA, QCUF, and reagent strips of 97% (95% confidence interval (CI): 91-100%), 86% (95% CI: 72-99%), and 67% (95% CI: 52-81%), respectively. Test specificities were consistently above 90%. CONCLUSIONS/SIGNIFICANCE: The UCP-LF CAA assay shows high sensitivity for the diagnosis of S. haematobium in low-endemicity settings. Empirically, it detects a considerably higher number of infections than microscopy. Hence, the UCP-LF CAA employed in combination with QCUF, is a promising tool for monitoring and surveillance of urogenital schistosomiasis in low-transmission settings targeted for elimination.
Assuntos
Antígenos de Helmintos/urina , Glicoproteínas/urina , Proteínas de Helminto/urina , Esquistossomose Urinária/diagnóstico , Urinálise/métodos , Animais , Antígenos de Helmintos/imunologia , Criança , Pré-Escolar , Humanos , Testes Imunológicos/métodos , Ilhas do Oceano Índico , Lactente , Masculino , Prevalência , Schistosoma haematobium/imunologia , Esquistossomose Urinária/imunologia , Sensibilidade e Especificidade , TanzâniaRESUMO
Urogenital schistosomiasis caused by Schistosoma haematobium induces a Th2 immune response, including expression of Interleukin-6. IL-6 confers protection from experimental Schistosoma-induced pulmonary hypertension and modulates production of mannose-binding lectin (MBL) and other lectins. We studied IL-6 levels in schistosomiasis and its effect on lectins production. Elevated IL-6 levels occurred in cases, compared to controls. IL-6 correlated with the lectins MBL, ficolin-2 and Collectin Kidney-1 (CL-K1) in cases, but correlated inversely in controls. The study shows that IL-6 levels are elevated in individuals infected with urogenital schistosomiasis. IL-6 was also found to be correlated with the production of lectins in S. haematobium infection. A similar correlation between IL-6 and MBL was observed during visceral leishmaniasis.